Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization

NCT01687712 is registered in ClinicalTrials.gov with Fertility Biotech AG as lead sponsor.

NCT NCT01687712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01687712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Lead sponsor
Fertility Biotech AG
Phase
Phase 3
Overall status
Completed
Start date
November 25, 2013
Completion date
November 14, 2016
Enrollment
1,100 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

infertility